Skip to main content
Clinical Trials/ISRCTN69440037
ISRCTN69440037CompletedPhase 3

Physiologically individualized therapy for resistant hypertension in Africa

Grand Challenges Canada0 sites120 target enrollmentStarted: May 31, 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Blood pressure greater than 160 systolic or 90 diastolic
  • 2.Currently on three medications including a diuretic
  • 3. Attending the hypertension clinic at the study site
  • 4. Aged 18 and over

Exclusion Criteria

  • 1. Renal failure
  • 2. Congestive heart failure
  • 3. Patients with a serious health condition that would limit life expectancy to less than one year

Investigators

Similar Trials